Medical Campus aerial
Hepatology Program

The Hepatology Program at Michigan Medicine is one of the largest and most prestigious programs in the world. Our team has excelled in research, education, and in providing compassionate care since 1954.
For More Information
Program Overview

Led by Dr. Neehar Parikh and Dr. Elliot Tapper, the Hepatology Program includes 18 faculty members and four advanced practice providers with world-leading expertise in a wide variety of liver diseases

Learn more about our program's leadership and history

Leading with excellence: The Division of Gastroenterology and Hepatology at the University of Michigan is the largest in the United States, with a large, dedicated team that takes a three-tiered approach to delivering care for liver disease.
About

Learn more about our program's history, our team members and our mission for providing state-of-the-art liver care.

Research

With a broad research portfolio, our program’s investigations span scientific, clinical and health services research.

Education

Our team is committed to the training of fellows in the GI Fellowship Program and Transplant Hepatology Fellowship Program.

Patient Care

Find clinic information, specialty clinics, procedure information and more.

Lectures & CME

During the year, we provide a variety of hepatology educational lectures and CME courses to U-M faculty as well as external health care providers.

See Opportunities
Featured News & Stories See all news Elliot Tapper
Department News
Internal Medicine Faculty Spotlight − Dr. Elliot Tapper
Elliott Tapper, MD, FASSLD is an Associate Professor of Internal Medicine and Academic Chief of Hepatology in the Division of Gastroenterology and Hepatology.
 Dr. Stidham in AGA News
Department News
How AI can help physicians: Dr. Stidham's interview in the American Gastroenterological Association News
Dr. Stidham's interview in AGA "GI Docs will need to forge a 'Human-Computer Cooperative'"
 syringes three in a row with one with a shot going into it on a light teal background
Health Lab
TNF inhibitors prevent complications in kids with Crohn’s disease, recommended as first-line therapies
Early treatment of pediatric Crohn’s disease with anti-tumor necrosis factor medications can substantially reduce the risk of perianal fistulas in Crohn’s disease. Michigan Medicine researchers confirmed this finding using prospective data. 
 man in pink shirt close up with hand on stomach
Health Lab
Potential culprit identified in lingering Crohn’s disease symptoms
A study from University of Michigan researchers may explain why some patients with Crohn’s disease continue to experience symptoms, even in the absence of inflammation.
 Clarivate’s Highly Cited Researchers 2024
Department News
Internal Medicine Faculty Named to Clarivate’s Highly Cited Researchers List
Nine faculty members from the Department of Internal Medicine named to Clarivate’s Highly Cited Researchers 2024 List.
 close up of sensor
Health Lab
Stent sensor can warn of blockages in the bile duct
Currently, medical providers monitor biliary stent blockages through blood tests, meaning the problem must be significant enough for the body to notice. A sensor within the stent could enable doctors to recognize that bacterial sludge is accumulating and intervene before the patient begins to fall ill.
Stay Connected With Us